Sfoglia per RIVISTA
CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY
Collezione AOU San Luigi di Orbassano

  

Items : 33

Role of osimertinib plus brain radiotherapy versus osimertinib single therapy in EGFR-mutated non-small-cell lung cancer with brain metastases: A meta-analysis and systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2025 Jan;205:104540. doi: 10.1016/j.critrevonc.2024.104540. Epub 2024 Oct 30

2025
AOU San Luigi di Orbassano

Nepote A; Poletto S; Bertaglia V; Carnio S; Piumatti C; Lanzetta C; Cantale O; Saba G; Bironzo P; Novello S; Tralongo AC;

Endocrinological toxicities related to immunotherapy combinations for advanced renal cell carcinoma: Practical expert-based management recommendations. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2025 Feb 6;209:104627. doi: 10.1016/j.critrevonc.2025.104627.

2025
AOU San Luigi di Orbassano
ASL Torino 3
ASL Asti

Colombo C; De Leo S; Campisi I; Palesandro E; Turco F; Buttigliero C; Fugazzola L; Tucci M;

Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2024 May;197:104328. doi: 10.1016/j.critrevonc.2024.104328. Epub 2024 Mar 13

2024
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Di Maio M; Novello S; Vellani G; Sperone P; Vignani F; Dionisio R; Ferrari G; Paratore C; Valsecchi AA;

Standardized and simplified reporting of next-generation sequencing results in advanced non-small-cell lung cancer: Practical indications from an Italian multidisciplinary group. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2024 Jan;193:104217. doi: 10.1016/j.critrevonc.2023.104217. Epub 2023 Nov 30

2024
AOU San Luigi di Orbassano

Malapelle U; Donne AD; Pagni F; Fraggetta F; Rocco EG; Pasello G; Perrone G; Pepe F; Vatrano S; Pignata S; Pinto C; Pruneri G; Russo A; Soto Parra HJ; Vallone S; Marchetti A; Troncone G; Novello S; Malapelle U; Donne AD; Pagni F; Fraggetta F; Rocco EG; Pasello G; Perrone G; Pepe F; Vatrano S; Pignata S; Pinto C; et alii...

Clinical evidence and adverse event management update of patients with RET- rearranged advanced non-small-cell lung cancer (NSCLC) treated with pralsetinib. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2024 Feb;194:104243. doi: 10.1016/j.critrevonc.2023.104243. Epub 2023 Dec 20

2024
AOU San Luigi di Orbassano

Russo GL; Bironzo P; Bennati C; Bonanno L; Catino A; Metro G; Petrini I; Russano M; Passaro A; Russo GL; Bironzo P; Bennati C; Bonanno L; Catino A; Metro G; Petrini I; Russano M; Passaro A;

Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factors. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Jan;181:103881. doi: 10.1016/j.critrevonc.2022.103881. Epub 2022 Nov 24

2023
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Scagliotti GV; Di Maio M; Brusa F; Audisio A; Di Stefano RF; Ungaro A; Audisio M; Samuelly A; Turco F; Tucci M; Delcuratolo MD;

Infections in lung cancer patients undergoing immunotherapy and targeted therapy: An overview on the current scenario. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Apr;184:103954. doi: 10.1016/j.critrevonc.2023.103954. Epub 2023 Mar 5.

2023
ASL Città di Torino
ASL Torino 3
AOU San Luigi di Orbassano

Novello S; Tampellini M; Scartozzi M; Manunta S; Solinas C; Denaro N; Aiello MM; Morelli AM; Bertaglia V;

Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Apr;184:103966. doi: 10.1016/j.critrevonc.2023.103966. Epub 2023 Mar 15

2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Scagliotti GV; Taulli R; Yoshizumi T; Novello S; Seto T; Haratake N; Takenaka T; Tabbò F; Picca F; Bersani F; Bironzo P; Toyokawa G;

New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jun;174:103682. doi: 10.1016/j.critrevonc.2022.103682. Epub 2022 Apr 11

2022
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Di Maio M; Scagliotti GV; Ortega C; Di Prima L; Audisio A; Turco F; Ungaro A; Di Stefano RF; Parlagreco E; Tucci M; Audisio M;

Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jan;169:103536. doi: 10.1016/j.critrevonc.2021.103536. Epub 2021 Nov 18

2022
AOU San Luigi di Orbassano

Malapelle U; Pilotto S; Reale ML; Passiglia F; Pisapia P; Pepe F; Belluomini L; Galetta D; Cortinovis D; Tiseo M; Passaro A; Seminati D; Pagni F; Parra HS; Migliorino MR; Rocco D; Troncone G; Novello S; Malapelle U; Pilotto S; Reale ML; Passiglia F; Pisapia P; Pepe F; Belluomini L; Galetta D; Cortinovis D; Tiseo M; Passaro A; et alii...

Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jan;169:103525. doi: 10.1016/j.critrevonc.2021.103525. Epub 2021 Nov 20

2022
AOU San Luigi di Orbassano

Pisapia P; Pepe F; Baggi A; Barberis M; Galvano A; Gristina V; Mastrilli F; Novello S; Pagni F; Pasini S; Perrone G; Righi D; Russo A; Troncone G; Malapelle U; Pisapia P; Pepe F; Baggi A; Barberis M; Galvano A; Gristina V; Mastrilli F; Novello S; Pagni F; Pasini S; Perrone G; Righi D; Russo A; Troncone G; et alii...

A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103639. doi: 10.1016/j.critrevonc.2022.103639. Epub 2022 Feb 19

2022
ASL Asti
AOU San Luigi di Orbassano

Passiglia F; Novello S; Buffoni L; Carnio S; Capelletto E; Zichi C; Reale ML; Artusio E; Olmetto E; Bungaro M; Paratore C; Bertaglia V; Audisio M; Rapetti SG; Pignataro D; Curcio H; De Luca E; Bironzo P; Tagliamento M; Scagliotti GV; Di Maio M;

The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103602. doi: 10.1016/j.critrevonc.2022.103602. Epub 2022 Jan 19

2022
AOU San Luigi di Orbassano

Fogli S; Tabbò F; Capuano A; Del Re M; Passiglia F; Cucchiara F; Scavone C; Gori V; Novello S; Schmidinger M; Danesi R;

Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103185. doi: 10.1016/j.critrevonc.2020.103185. Epub 2020 Nov 27

2021
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Pisano C; Tucci M; Di Stefano RF; Turco F; Scagliotti GV; Di Maio M;

Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103189. doi: 10.1016/j.critrevonc.2020.103189. Epub 2020 Nov 27

2021
AOU San Luigi di Orbassano

Sperone P; Capelletto E; Artusio E; Carnio S; Di Stefano RF; Rapetti S; Audisio M; Bungaro M; Tabbò F; Leone G; Mariniello A; Palesandro E; Bironzo P; Reale ML; Bertaglia V; Passiglia F; Novello S;

Exploring the role of respiratory microbiome in lung cancer: A systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Aug;164:103404. doi: 10.1016/j.critrevonc.2021.103404. Epub 2021 Jun 29

2021
ASL Asti
AOU San Luigi di Orbassano

Galetta D; Tiseo M; Menis J; Facchinetti F; Bironzo P; Sartori G; Russano M; Rinaldi S; Prelaj A; Pignataro D; Montrone M; Meacci F; Di Noia V; Bianconi M; Mazzotta M; Perrone F; Belluomini L; Novello S; Pilotto S;

Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Apr;160:103300. doi: 10.1016/j.critrevonc.2021.103300. Epub 2021 Mar 17

2021
AOU San Luigi di Orbassano

Malapelle U; Pilotto S; Passiglia F; Pepe F; Pisapia P; Righi L; Listì A; Bironzo P; Belluomini L; Tabbò F; Reale ML; Russo G; De Luca C; Novello S; Troncone G;

Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Feb;146:102877. doi: 10.1016/j.critrevonc.2020.102877. Epub 2020 Jan 18

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Novello S; Aglietta M; Leone F; Sonetto C; La Salvia A; Muratori L; Leone G; Trevisi E; Mariniello A; Ghisoni E; Di Stefano RF; Pignataro D; Reale ML; Zichi C; De Luca E; Marandino L; Lombardi P; Perrone F; Di Maio M;

Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Feb;146:102858. doi: 10.1016/j.critrevonc.2019.102858. Epub 2019 Dec 28

2020
AOU San Luigi di Orbassano

Rossi G; Ramella S; Passaro A; Menis J; Malapelle U; Franchina T; Ferrara R; Del Re M; Bertolaccini L; Facchinetti F; Pilotto S; Passiglia F; Trisolini R; Novello S;

Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Aug;152:102994. doi: 10.1016/j.critrevonc.2020.102994. Epub 2020 May 24

2020
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tucci M; Di Maio M; Scagliotti GV; Vignani F; Tabbò F; Turco F; Di Stefano RF; Buttigliero C; Pisano C; Leone G;

Double immune checkpoint blockade in advanced NSCLC. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Aug;152:102980. doi: 10.1016/j.critrevonc.2020.102980. Epub 2020 May 19

2020
AOU San Luigi di Orbassano

Mariniello A; Novello S; Scagliotti GV; Ramalingam SS;

Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Apr;148:102862. doi: 10.1016/j.critrevonc.2019.102862. Epub 2020 Jan 25

2020
AOU San Luigi di Orbassano

Passiglia F; Bertolaccini L; Del Re M; Facchinetti F; Ferrara R; Franchina T; Malapelle U; Menis J; Passaro A; Pilotto S; Ramella S; Rossi G; Trisolini R; Novello S;

Target therapies in recurrent or metastatic head and neck cancer: state of the art and novel perspectives. A systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Jul;139:41-52. doi: 10.1016/j.critrevonc.2019.05.002. Epub 2019 May 3.

2019
AOU San Luigi di Orbassano

Muratori L; La Salvia A; Sperone P; Di Maio M;

Corrigendum to "Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario" [Crit. Rev. Oncol./Hematol. 122 (February) (2018) 150-156]. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Jul;139:158. doi: 10.1016/j.critrevonc.2018.06.018. Epub 2018 Nov 2.

2019
AOU San Luigi di Orbassano

Addeo A; Tabbò F; Robinson T; Buffoni L; Novello S;

Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Sep;129:124-132. doi: 10.1016/j.critrevonc.2018.07.004. Epub 2018 Jul 1

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Ardizzoni A; Zichi C; Gatto L; Vignani F; Tucci M; Buttigliero C; De Luca E; Di Nunno V; Massari F;

A systematic review of the safety profile of the different combinations of fluoropyrimidines and oxaliplatin in the treatment of colorectal cancer patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Feb;122:21-29. doi: 10.1016/j.critrevonc.2017.12.010. Epub 2017 Dec 16.

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tampellini M; Scagliotti GV; Brizzi MP; Sonetto C; Di Maio M; Zichi C; Baratelli C;

Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Feb;122:150-156. doi: 10.1016/j.critrevonc.2017.12.015. Epub 2017 Dec 3

2018
AOU San Luigi di Orbassano

Buffoni L; Novello S; Robinson T; Tabbò F; Addeo A;

Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Dec;132:9-16. doi: 10.1016/j.critrevonc.2018.09.008. Epub 2018 Sep 14.

2018
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Gay F; Nagler A; Boccadoro M; Montefusco V; Palumbo A; Ribolla R; Siniscalchi A; Patriarca F; Pezzatti S; De Sabbata G; Di Renzo N; Rizzi R; Gamberi B; Baldini L; Guglielmelli T; Gilestro M; Catalano L; Marcatti M; Spada S; Petrucci MT; Ria R; Offidani M; De Paoli L; Conticello C; D'Agostino M;

Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Apr;124:21-28. doi: 10.1016/j.critrevonc.2018.02.001. Epub 2018 Feb 7.

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Sperti E; Marcato M; Bria E; Vignani F; Bironzo P; Baratelli C; Di Maio M; Roila F;

Chemical shift and diffusion-weighted magnetic resonance imaging of the anterior mediastinum in oncology: Current clinical applications in qualitative and quantitative assessment. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2016 Feb;98:335-57. doi: 10.1016/j.critrevonc.2015.11.012. Epub 2015 Nov 23.

2016
AOU San Luigi di Orbassano

Veltri A; Priola SM; Gned D; Priola AM;

Functional imaging in predicting response to antineoplastic agents and molecular targeted therapies in lung cancer: a review of existing evidence. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2012 Aug;83(2):208-15. doi: 10.1016/j.critrevonc.2011.09.009. Epub 2011 Nov

2012
AOU San Luigi di Orbassano

Novello S; Giaj Levra M; Vavalà T;

Proteasome inhibitors in lung cancer. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2006 Jun;58(3):177-89. doi: 10.1016/j.critrevonc.2005.12.001. Epub 2006 Jan

2006
AOU San Luigi di Orbassano

Scagliotti G;

Management of bone metastases in cancer: a review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2005 Dec;56(3):365-78. doi: 10.1016/j.critrevonc.2005.03.011. Epub 2005 Jun

2005
AOU San Luigi di Orbassano

Selvaggi G; Scagliotti GV;